Arterica
Santa Rosa, US · Founded 2019 · Delaware corporation
Arterica is a medical device startup developing a large-bore vascular closure device aimed at improving patient outcomes and lowering healthcare costs. Founded in 2016, it serves cardiologists and vascular surgeons in the cardiovascular device field.
Founders & leadership
RG
Robert G. WhirleyPresident and CEO
TL
Thomas LarzonChief Medical Officer
JW
Joseph W. HumphreyChief Operating Officer
CR
Charlie RampersaudNamed on SEC filing
TT
Tobias TullbertNamed on SEC filing
TS
Thorsten SiessNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$6.3M disclosed across 3 rounds · 2019–2023
▶$2.5MraisedMay 2023 · 1 investors · BiotechnologyRule 506(b)
▶$2.5MraisedMay 2023 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Tobias TullbergDirector
- Thomas LarzonDirector
- Robert WhirleyExecutive Officer, Director
- Charlie RampersaudDirector
- Thorsten SiessDirector
- Joseph HumphreyExecutive Officer
- Offering amount
- $5M
- Amount sold
- $2.5M
- Minimum investment
- $25K
- First sale
- May 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$805KraisedOct 2021 · 10 investors · BiotechnologyRule 506(b)
▶$805KraisedOct 2021 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- ROBERT G. WHIRLEYExecutive Officer, Director
- THOMAS A. LARZONDirector
- CHARLIE RAMPERSAUDDirector
- JOSEPH HUMPHREYExecutive Officer
- TOBIAS TULLBERGDirector
- THORSTEN SIESSDirector
- Offering amount
- $1M
- Amount sold
- $805K
- Minimum investment
- $25K
- First sale
- Oct 2021
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$3MraisedJul 2019 · 1 investors · BiotechnologyRule 506(b)
▶$3MraisedJul 2019 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robert G. WhirleyExecutive Officer, Director
- Charlie RampersaudDirector
- Thomas LarzonDirector
- Tobias TullbertDirector
- Thorsten SiessDirector
- Offering amount
- $3M
- Amount sold
- $3M
- Minimum investment
- $3M
- First sale
- Jul 2019
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlapCordicamedical6 shared keywordsCordica Medical provides design, development, and manufacturing services for medical device companies, covering product engineering, precision manufacturing, automated assembly, packaging, and supply chain management through FDA-registered and ISO 13485-certified facilities. It supports programs across therapeutic areas including interventional systems, drug delivery, wound care, and personal health, operating 19 facilities in the United States, Mexico, and Singapore.
Redica5 shared keywordsRedica offers an AI-enriched intelligence platform that unifies global regulatory, inspection, site, and post-market data to help companies manage risk and protect product quality. It serves quality, regulatory, and supply chain teams across industries including pharmaceutical, medtech, cosmetics, supplements, food, and financial services.
Latica5 shared keywordsLatica provides a secure data collaboration platform for healthcare organizations and research teams, comprising a Trusted Data Environment and Data Exchange that enable analysis of anonymized medical data while maintaining patient privacy and data ownership.
Companies competing with Arterica for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Arterica do?
- Arterica is a medical device startup developing a large-bore vascular closure device aimed at improving patient outcomes and lowering healthcare costs. Founded in 2016, it serves cardiologists and vascular surgeons in the cardiovascular device field.
- How much funding has Arterica raised?
- Arterica has disclosed $6.3M raised across 3 rounds.
- Where is Arterica headquartered?
- Arterica is headquartered in Santa Rosa, US.